The latest closing stock price for Revance Therapeutics as of January 31, 2025 is 3.63.
An investor who bought $1,000 worth of Revance Therapeutics stock at the IPO in 2014 would have $-865 today, roughly -1 times their original investment - a -16.63% compound annual growth rate over 11 years.
The all-time high Revance Therapeutics stock closing price was 40.78 on November 11, 2015.
The Revance Therapeutics 52-week high stock price is 7.56, which is 108.3% above the current share price.
The Revance Therapeutics 52-week low stock price is 2.30, which is 36.6% below the current share price.
The average Revance Therapeutics stock price for the last 52 weeks is 4.39.
An investor who bought $1,000 worth of Revance Therapeutics stock at the IPO in 2014 would have $-865 today, roughly -1 times their original investment - a -16.63% compound annual growth rate over 11 years.
The all-time high Revance Therapeutics stock closing price was 40.78 on November 11, 2015.
The Revance Therapeutics 52-week high stock price is 7.56, which is 108.3% above the current share price.
The Revance Therapeutics 52-week low stock price is 2.30, which is 36.6% below the current share price.
The average Revance Therapeutics stock price for the last 52 weeks is 4.39.